CASI PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
CASI PHARMACEUTICALS, INC. reported Share-based Payment Arrangement, Expense of $30.50 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-03-29
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2015-09-30 was $321.29K, a 53.21% decline year-over-year.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2015-06-30 was $472.75K, a 3.88% decline year-over-year.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2015-03-31 was $399.37K, a 7.23% increase year-over-year.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2014-12-31 was -$1.17M.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2017 was $30.50K, a 201.98% increase from fiscal 2016.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2016 was $10.10K.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2014 was $686.60K, a 66.42% decline from fiscal 2013.
- CASI PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2013 was $2.04M, a 108.99% increase from fiscal 2012.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $30.50K 10-K · filed 2018-03-29 | |||
| 2016-12-31 | $10.10K 10-K · filed 2018-03-29 | |||
| 2015-09-30 | $321.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $794.04K derived: sum of 2 quarters · filed 2015-11-13 | $1.19M 10-Q · filed 2015-11-13 | $27.71K derived: sum of 4 quarters · filed 2015-11-13 |
| 2015-06-30 | $472.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $872.13K 10-Q · filed 2015-08-14 | -$293.58K derived: sum of 3 quarters · filed 2015-08-14 | $393.02K derived: sum of 4 quarters · filed 2015-08-14 |
| 2015-03-31 | $399.37K 10-Q · filed 2015-05-15 | -$766.34K derived: sum of 2 quarters · filed 2015-05-15 | -$79.74K derived: sum of 3 quarters · filed 2015-05-15 | $412.07K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | -$479.11K derived: sum of 2 quarters · filed 2015-03-27 | $12.70K derived: sum of 3 quarters · filed 2015-08-14 | $686.60K 10-K · filed 2015-03-27 |
| 2014-09-30 | $686.60K 10-Q · filed 2014-11-14 | $1.18M derived: sum of 2 quarters · filed 2015-08-14 | $1.85M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $491.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $864.26K 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $372.45K 10-Q · filed 2015-05-15 | |||
| 2013-12-31 | $2.04M 10-K · filed 2014-03-21 | |||
| 2012-12-31 | $978.24K 10-K · filed 2014-03-21 |